Note: Ingredients listed on restricted chemical lists
EC/CAS
9005-64-5
Name of the chemical
polyethyleneglycol sorbitan monolaurate
Concentration
N/A
EC/CAS
77-92-9
Name of the chemical
Citric acid
Concentration
N/A
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
N/A
General Information
Revision date
2025-11-24
Product name
Risperidone for ER Injectable Suspension
1.2.1 Relevant identified uses
of the substance or Pharmaceutical mixture
Manufacturer Name
Nanomi B.V., a Lupin Group Company
Icons in SDS
Company Information
company name
Nanomi B.V., a Lupin Group Company
Section 2
SECTION 2: Hazards identification
Health Do not use it until all safety precautions have been read and understood. Known hypersensitivity to risperidone or any excipients in risperidone for extended-release injectable suspension. Please refer to the product information/ Package insert for appropriate consumer-specific information about this product when used according to the physician’s directions.
Environmental hazards
Dispose of content and/or container in accordance with local, regional, national, and/or international regulations.
